|LETTER TO THE EDITOR
|Year : 2018 | Volume
| Issue : 8 | Page : 1230
Comment on: A rare case of unilateral diffuse melanocytic proliferation
Mohit Dogra, Simar Rajan Singh, Ramandeep Singh, Mangat Ram Dogra
Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
|Date of Web Publication||23-Jul-2018|
Dr. Mohit Dogra
Advanced Eye Centre, Post Graduate Institute of Medical Education and Research, Chandigarh
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Dogra M, Singh SR, Singh R, Dogra MR. Comment on: A rare case of unilateral diffuse melanocytic proliferation. Indian J Ophthalmol 2018;66:1230
|How to cite this URL:|
Dogra M, Singh SR, Singh R, Dogra MR. Comment on: A rare case of unilateral diffuse melanocytic proliferation. Indian J Ophthalmol [serial online] 2018 [cited 2020 May 26];66:1230. Available from: http://www.ijo.in/text.asp?2018/66/8/1230/237343
We read with great interest the case report by Ayachit et al. describing unilateral presentation of diffuse uveal melanocytic proliferation (DUMP) syndrome. The authors must be complemented on immaculate documentation of this rare case with multimodal imaging.
However, a couple of areas need clarification. Oral tamoxifen was started for this patient with biopsy-proven metastatic breast cancer as the tumor had estrogen and progesterone receptor (PR) positivity. Tamoxifen has been shown to be the treatment of choice for postmenopausal females with PR-positive metastatic breast cancer. How did the primary site respond to chemotherapy? If the tumor reduced in size after chemotherapy, is it not possible that the paraneoplastic syndrome associated with it would also reduce in severity/intensity?
Second, DUMP is a paraneoplastic phenomenon and hence to institute intravitreal bevacizumab (IVB) therapy for this entity defies logic. Furthermore, regression shown by the authors on optical coherence tomography is after 2 months after starting tamoxifen and IVB. The authors site the report by Lin et al., in which the efficacy of IVB for choroidal metastasis due to colon cancer is highlighted. DUMP is distinct from metastasis and occurs due to distant effect of the primary tumor. To ascribe the resolution of subretinal fluid and improvement of visual acuity solely to IVB would be incorrect, especially when it is known that even plasmapheresis/steroids do not work in most cases of DUMP.,
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Ayachit G, Ayachit A, Joshi S, Vasudevan SV. A rare case of unilateral diffuse melanocytic proliferation. Indian J Ophthalmol 2018;66:588-90.
] [Full text]
Bergh J, Jönsson PE, Glimelius B, Nygren P; SBU-group. Swedish Council of Technology Assessment in Health Care. A systematic overview of chemotherapy effects in breast cancer. Acta Oncol 2001;40:253-81.
Lin CJ, Li KH, Hwang JF, Chen SN. The effect of intravitreal bevacizumab treatment on choroidal metastasis of colon adenocarcinoma – case report. Eye (Lond) 2010;24:1102-3.
Schelvergem KV, Wirix M, Nijs I, Leys A. Bilateral diffuse uveal melanocytic proliferation with good clinical response to plasmapheresis and treatment of the primary tumor. Retin Cases Brief Rep 2015;9:106-8.
Moreno TA, Patel SN. Comprehensive review of treatments for bilateral diffuse uveal melanocytic proliferation: A focus on plasmaphereis. Int Ophthalmol Clin 2017;57:177-94.